Nuvation Bio Inc (NUVB)
9.72
+0.13 +1.36%
NYSE
Jun 24, 16:59
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -- |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -- |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0% |
| Price and Valuation | |
| Market Cap | 2.117B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | -- |
| PE Ratio | -- |
| Price to Book Value | -- |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | -- |
| Free Cash Flow (Quarterly) | -14.84M |
| Return on Equity | Upgrade |
View All NUVB News
News
-
WireHeadlineTime (ET)
-
SA Breaking News06/19 05:38
-
PR Newswire06/01 07:00
-
PR Newswire05/26 07:00
-
Yahoo05/21 16:34
-
MT Newswires05/18 11:19
-
PR Newswire05/17 17:00
-
Yahoo05/11 05:51
-
Yahoo04/17 21:36
-
SA Breaking News04/07 09:15
-
MT Newswires04/06 11:00
-
SA Breaking News03/11 17:26
-
PR Newswire03/11 17:15
-
MT Newswires03/11 08:02
-
SA Breaking News03/11 08:00
-
PR Newswire03/11 07:00
-
MT Newswires03/08 09:31
-
MT Newswires03/08 09:31
-
MT Newswires03/08 09:31
-
MT Newswires03/08 09:30
-
MT Newswires03/08 06:37
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 08/13/2021 | Earnings Results | Q2 2021 Earnings Results |
| 05/17/2021 | Earnings Results | Q1 2021 Earnings Results |
| 03/11/2021 | Earnings Results | Q4 2020 Earnings Results |
| 11/16/2020 | Earnings Results | Q3 2020 Earnings Results |
| 08/14/2020 | Earnings Results | Q2 2020 Earnings Results |
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.
- URL: https://www.nuvationbio.com
- Investor Relations URL: N/A
- HQ State/Province: New York
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: N/A
- Next Earnings Release: Aug. 13, 2021
- Last Earnings Release: May. 17, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 9.72 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- NUVB Tweets Stocktwits
Advertisement
